Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Enhanced Suppression of the Secondary Immune Response by Combination of 6-Mercaptopurine ‘Duazomycin A

Abstract

THE demonstration that 6-mercaptopurine (6-MP) is capable of inhibiting the immune response1,2 has aroused much interest and optimism concerning the therapeutic possibilities for organ transplantation and ‘auto-immune’ diseases. Extension of these studies has shown that immunological tolerance can be obtained by administration of 6-MP during the primary exposure to an antigen3. Although initial attempts to modify the secondary response to the antigen were unsuccessful4, a quantitative rather than qualitative effect seems to have been responsible, since proper timing and vigorous treatment with both antigen and drug will achieve complete suppression of specific antibody production in previously immunized animals5,6.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Schwartz, R., Stack, J., and Dameshek, W., Proc. Soc. Exp. Biol., 99, 164 (1958).

    Article  CAS  Google Scholar 

  2. Schwartz, R., and Dameshek, W., J. Clin. Invest., 39, 952 (1960).

    Article  CAS  Google Scholar 

  3. Schwartz, R., and Dameshek, W., Nature, 183, 1682 (1959).

    Article  ADS  CAS  Google Scholar 

  4. Schwartz, R., Eisner, A., and Dameshek, W., J. Clin. Invest., 38, 1394 (1959).

    Article  CAS  Google Scholar 

  5. Condie, R. M., Mennis, W. I., and Miller, C., Fed. Proc., 20, 26 (1961).

    Google Scholar 

  6. LaPlante, E. S., Condie, R. M., and Good, R. A., J. Lab. Clin. Med., 59, 542 (1962).

    CAS  PubMed  Google Scholar 

  7. Calabresi, P., and Welch, A. D., Ann. Rev. Med., 13, 147 (1962).

    Article  CAS  Google Scholar 

  8. LePage, G. A., Clin. Pharm. Therap., 2, 131 (1961).

    Article  Google Scholar 

  9. Tarnowski, G. S., and Stock, C. C., Cancer Res., 17, 1033 (1957).

    CAS  Google Scholar 

  10. Heyh, R. M., Brubaker, C. A., Burchenal, J. H., Cramblett, H. G., and Wolff, J. A., Blood, 15, 350 (1960).

    Google Scholar 

  11. Sullivan, Margaret, Beatty, E. C., Hyman, C. B., Murphy, M. L., Pierce, M. I., and Severo, N. C., Cancer Chemother. Rep., 16, 161 (1962).

    CAS  PubMed  Google Scholar 

  12. Lefkowitz, E. R., Creasey, W. A., Calabresi, P., and Sartorelli, A. C., Proc. Amer. Assoc. Cancer Res., 4, 37 (1963).

    Google Scholar 

  13. Boyden, S. V., J. Exp. Med., 93, 107 (1951).

    Article  CAS  Google Scholar 

  14. Stavitsky, A. B., J. Immunol., 72, 360 (1954).

    CAS  Google Scholar 

  15. Stavitsky, A. B., J. Immunol., 72, 368 (1954).

    CAS  PubMed  Google Scholar 

  16. Alexandre, G. P. J., and Murray, J. D., Surgical Forum, 13, 64 (1962).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ROSENBERG, S., CALABRESI, P. Enhanced Suppression of the Secondary Immune Response by Combination of 6-Mercaptopurine ‘Duazomycin A . Nature 199, 1101–1102 (1963). https://doi.org/10.1038/1991101a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/1991101a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing